|
US4977189A
(en)
*
|
1986-05-07 |
1990-12-11 |
American Cyanamid Company |
Substituted guanidinedicarbonyl derivatives
|
|
JPH07188197A
(ja)
|
1993-11-17 |
1995-07-25 |
Fujisawa Pharmaceut Co Ltd |
オキサゾール誘導体
|
|
DE4344550A1
(de)
|
1993-12-24 |
1995-06-29 |
Hoechst Ag |
Substituierte 1-Oxo-1,2-dihydro-isochinolinoyl- und 1,1-Dioxo-2H-1,2-benzothiazinoylguanidine, Verfahrenzu ihrer Herstellung, ihre Verwendung als Medikamentt oder Diagnostikum sowie sie enthaltendes Medikamen
|
|
US7041702B1
(en)
|
1997-10-21 |
2006-05-09 |
Scion Pharmaceuticals, Inc. |
Pharmaceutically active compounds and methods of use
|
|
AU760174B2
(en)
|
1999-02-09 |
2003-05-08 |
Bristol-Myers Squibb Company |
Lactam inhibitors of FXa and method
|
|
US7276348B2
(en)
|
1999-04-30 |
2007-10-02 |
Regents Of The University Of Michigan |
Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof
|
|
AU5852300A
(en)
|
1999-07-15 |
2001-02-05 |
Sumitomo Pharmaceuticals Company, Limited |
Heteroaromatic ring compounds
|
|
EP1296978A2
(en)
|
2000-06-30 |
2003-04-02 |
Bristol-Myers Squibb Company |
N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity
|
|
WO2003050261A2
(en)
|
2001-12-10 |
2003-06-19 |
Bristol-Myers Squibb Company |
(1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase
|
|
GB0208224D0
(en)
|
2002-04-10 |
2002-05-22 |
Celltech R&D Ltd |
Chemical compounds
|
|
WO2003106628A2
(en)
|
2002-06-17 |
2003-12-24 |
Bristol-Myers Squibb Company |
Benzodiazepine inhibitors of mitochondial f1f0 atp hydrolase and methods of inhibiting f1f0 atp hydrolase
|
|
WO2004043362A2
(en)
|
2002-11-06 |
2004-05-27 |
Bristol-Myers Squibb Company |
Acyl guanidine compounds and use thereof
|
|
ATE440827T1
(de)
|
2002-12-04 |
2009-09-15 |
Ore Pharmaceuticals Inc |
Melanocortin-rezeptormodulatoren
|
|
DE102004008141A1
(de)
|
2004-02-19 |
2005-09-01 |
Abbott Gmbh & Co. Kg |
Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren
|
|
US20090275099A1
(en)
|
2004-04-27 |
2009-11-05 |
Regents Of The University Of Michigan |
Methods and compositions for treating diseases and conditions associated with mitochondrial function
|
|
US20050272723A1
(en)
|
2004-04-27 |
2005-12-08 |
The Regents Of The University Of Michigan |
Methods and compositions for treating diseases and conditions associated with mitochondrial function
|
|
JP4990766B2
(ja)
|
2004-07-01 |
2012-08-01 |
シンタ ファーマシューティカルズ コーポレーション |
二置換型ヘテロアリール化合物
|
|
CA2659549C
(en)
|
2006-06-09 |
2013-07-30 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
ES2614498T3
(es)
*
|
2007-09-14 |
2017-05-31 |
The Regents Of The University Of Michigan |
Inhibidores de ATPasa F1F0 y métodos relacionados
|
|
CA2709784A1
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
KR100982661B1
(ko)
|
2008-04-22 |
2010-09-17 |
전남대학교산학협력단 |
플라스멥신 ⅱ 활성을 저해하는 화합물을 유효성분으로함유하는 말라리아 예방 및 치료를 위한 약학 조성물 및이를 이용한 말라리아 치료방법
|
|
JP5567573B2
(ja)
|
2008-09-11 |
2014-08-06 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
アリールグアニジンｆ１ｆ０−ａｔｐアーゼ阻害剤およびそれと関連する方法
|
|
US9169199B2
(en)
|
2010-12-08 |
2015-10-27 |
Lycera Corporation |
Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof
|
|
ES2639439T3
(es)
*
|
2010-12-08 |
2017-10-26 |
Lycera Corporation |
Inhibidores de F1F0-ATPasas de tipo pirazolilguanidina y sus usos terapéuticos de éstos
|
|
CA2820035A1
(en)
*
|
2010-12-08 |
2012-06-14 |
Lycera Corporation |
Cycloalkyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
|
|
WO2012078869A1
(en)
|
2010-12-08 |
2012-06-14 |
Lycera Corporation |
Pyridonyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
|
|
US9580391B2
(en)
|
2012-06-08 |
2017-02-28 |
Lycera Corporation |
Saturated acyl guanidine for inhibition of F1F0-ATPase
|
|
WO2013185045A1
(en)
|
2012-06-08 |
2013-12-12 |
Lycera Corporation |
Indazole guanidine f1f0-atpase inhibitors and therapeutic uses thereof
|
|
EP2866893A4
(en)
|
2012-06-08 |
2015-12-23 |
Lycera Corp |
HETEROCYCLIC GUANIDINE F1FO ATPASE INHIBITORS
|
|
EP3080089B1
(en)
|
2013-12-10 |
2019-05-08 |
Lycera Corporation |
Trifluoromethyl pyrazolyl guanidine f1fo-atpase inhibitors and therapeutic uses thereof
|
|
CA2931792A1
(en)
|
2013-12-10 |
2015-06-18 |
Lycera Corporation |
N-substituted pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
|
|
AU2014363958B2
(en)
*
|
2013-12-10 |
2018-11-08 |
Lycera Corporation |
Alkylpyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof
|